Pulse Biosciences (FRA:6L8) Cyclically Adjusted Book per Share: €1.43 (As of Mar. 2026)


FRA:6L8 Pulse Biosciences Inc FRA:6L8
31 GF Score
Price €23.60
! 3 Warning Signs
View Full Analysis

What is Pulse Biosciences Cyclically Adjusted Book per Share?

Pulse Biosciences FRA:6L8 -3.28% 31 Cyclically Adjusted Book per Share is €1.43 as of Mar. 2026. GuruFocus rates FRA:6L8 with a GF Score™ of 31/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pulse Biosciences's adjusted book value per share for the three months ended in Mar. 2026 was €0.841. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.43 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Pulse Biosciences's average Cyclically Adjusted Book Growth Rate was 1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-11), Pulse Biosciences's current stock price is €23.60. Pulse Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €1.43. Pulse Biosciences's Cyclically Adjusted PB Ratio of today is 16.50.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Pulse Biosciences was 16.14. The lowest was 7.23. And the median was 10.54.


Pulse Biosciences  (FRA:6L8) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pulse Biosciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=23.60/1.43
=16.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Pulse Biosciences was 16.14. The lowest was 7.23. And the median was 10.54.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pulse Biosciences Cyclically Adjusted Book per Share Related Terms


Pulse Biosciences Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Pulse Biosciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pulse Biosciences Cyclically Adjusted Book per Share Chart

Pulse Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 1.73 1.54

Pulse Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.68 1.51 1.52 1.54 1.43

FRA:6L8 vs LMAT, XRAY, KMTS: Cyclically Adjusted Book per Share Comparison

For the Medical Instruments & Supplies subindustry, Pulse Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulse Biosciences Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pulse Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pulse Biosciences's Cyclically Adjusted PB Ratio falls into.


FRA:6L8
31GF Score
Pulse Biosciences Inc FRA:6L8
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pulse Biosciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pulse Biosciences's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.841/330.2130*330.2130
=0.841

Current CPI (Mar. 2026) = 330.2130.

Pulse Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201606 2.003 241.018 2.744
201609 1.833 241.428 2.507
201612 1.771 241.432 2.422
201703 1.773 243.801 2.401
201706 1.475 244.955 1.988
201709 2.521 246.819 3.373
201712 2.272 246.524 3.043
201803 1.942 249.554 2.570
201806 1.747 251.989 2.289
201809 1.393 252.439 1.822
201812 2.784 251.233 3.659
201903 2.484 254.202 3.227
201906 2.089 256.143 2.693
201909 1.760 256.759 2.264
201912 1.306 256.974 1.678
202003 0.928 258.115 1.187
202006 1.470 257.797 1.883
202009 1.080 260.280 1.370
202012 0.724 260.474 0.918
202103 0.638 264.877 0.795
202106 1.647 271.696 2.002
202109 1.337 274.310 1.609
202112 1.045 278.802 1.238
202203 0.623 287.504 0.716
202206 0.587 296.311 0.654
202209 0.165 296.808 0.184
202212 -0.056 296.797 -0.062
202303 -0.261 301.836 -0.286
202306 1.003 305.109 1.086
202309 0.874 307.789 0.938
202312 0.725 306.746 0.780
202403 0.594 312.332 0.628
202406 0.454 314.175 0.477
202409 1.159 315.301 1.214
202412 1.664 315.605 1.741
202503 1.629 319.799 1.682
202506 1.347 322.561 1.379
202509 1.166 324.800 1.185
202512 1.015 324.054 1.034
202603 0.841 330.213 0.841

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €1.43 mean?
Pulse Biosciences (FRA:6L8) has a Cyclically Adjusted Book per Share of €1.43 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pulse Biosciences and its competitors.
Is Pulse Biosciences' Cyclically Adjusted Book per Share too high?
Pulse Biosciences' current Cyclically Adjusted Book per Share is €1.43. Overall, Pulse Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Pulse Biosciences' Cyclically Adjusted Book per Share compare to LMAT and XRAY?
Pulse Biosciences' Cyclically Adjusted Book per Share of €1.43 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pulse Biosciences and its competitors. Pulse Biosciences's current Cyclically Adjusted Book per Share is €1.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulse Biosciences stock overvalued right now?
Pulse Biosciences (FRA:6L8) has a current Cyclically Adjusted Book per Share of €1.43. The current Cyclically Adjusted Book per Share is €1.43. Pulse Biosciences' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Pulse Biosciences (FRA:6L8), the current Cyclically Adjusted Book per Share is €1.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pulse Biosciences Business Description

Other Exchanges PLSE:USA
Address 601 Brickell Key Drive, Suite 1080, Miami, FL, USA, 33131
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
31GF Score

Get the complete analysis for FRA:6L8

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.60
Price